Toggle light / dark theme

Scientists discover new Alzheimer’s drug that repairs DNA damage and reduces brain inflammation

Scientists have discovered that a drug originally developed for spinal cord injuries can tackle several key features of Alzheimer’s disease, including DNA damage and inflammation. Already tested for initial safety in humans, the experimental treatment could offer a faster path toward therapies that target the disease at its roots.

Enhancing the cell’s natural recycling center improves Alzheimer’s features in animal models

A defining feature of Alzheimer’s disease is the abnormal, sustained accumulation of protein aggregates such as tau inside brain cells, which disrupts the cells’ normal functions. As time passes, brain cells stop working and die, leading to a gradual decline in memory and thinking skills and other symptoms of this condition.

One goal of researchers is to find ways to reduce or stop the accumulation of tau and other related proteins to slow down or prevent disease progression.

At Baylor College of Medicine and the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas Children’s Hospital, a team of researchers has just taken a step in that direction. They have discovered that reducing the levels of a protein called Slingshot-1 has the unanticipated effect of improving Alzheimer’s features in animal models and human cells in the lab.

Randomized trial demonstrates enhanced stent expansion in severely calcified coronary nodules

A randomized clinical trial at The Mount Sinai Hospital found that combining two techniques for removing calcium nodules-rotational atherectomy and intravascular lithotripsy (IVL)-before coronary stent placement allowed stents to expand more fully than IVL alone in patients with calcified coronary nodules.

Light-activated catalyst makes sustainable production of hydrogen peroxide more efficient

Hydrogen peroxide (H₂O₂) is a versatile chemical feedstock whose industrial production relies predominantly on an energy-intensive process with a substantial environmental footprint. One alternative is to produce it using a catalyst activated by light. In an international research project involving the Max Planck Institute of Colloids and Interfaces, researchers have now developed a synthesis strategy that allows them to precisely control the spatial arrangement of ions in a carbon nitride. The resulting photocatalyst is three times as efficient as conventional green production methods. The findings have been published in Advanced Materials.

Hydrogen peroxide is an environmentally friendly oxidizing agent. When it decomposes, it produces only water and oxygen, which is why it is also known as a “green chemical.” As demand grows, particularly for environmentally friendly wastewater treatment and household and medical disinfection, production volumes continue to rise.

To meet this demand, hydrogen peroxide is still produced predominantly using the so-called anthraquinone process, which incurs high energy costs and has a substantial carbon footprint. Photocatalysis is a promising alternative. In this process, a material absorbs light and uses its energy to drive a chemical reaction without fossil energy. The efficiency of the reaction depends, among other things, on how readily the charges generated by light can move through the material and how long they remain available to drive the reaction.

A new way to replace carbon with nitrogen atoms could lead to better medicines

When drugmakers want to improve on compounds they have already created, they can replace a carbon atom with a nitrogen atom. While effective, the techniques they use to perform this chemical swap, known as skeletal editing, have some downsides. For example, older approaches often require harsh chemicals or only work on specific types of molecules.

That got researchers led by Mark D. Levin at the University of Chicago searching for a gentler and more versatile way to do it. Unlike older methods that fail when a specific chemical step goes wrong, their new technique turns that exact problem into a helpful tool.

The Lancet Commission on 21st century global threats to health

Just published @The Lancet

Global threats to health in the 21st century an opus, 59 page comprehensive dissection of all the threats we face.


This report from the Lancet Commission on 21st century global threats to health lays out a foresight-driven, health-focused approach to identifying and prioritising major threats to global health over the remainder of the century. We argue that recent global shocks (including COVID-19, Ebola Bundibugyo virus disease, major geopolitical conflict, accelerating climate impacts, rapid shifts in development assistance, and the emergence of powerful artificial intelligence [AI] systems) show how quickly assumptions about stability can be overturned—and why governments and multilateral institutions must counter short-termism and localism with systematic, repeatable risk assessment and preparedness planning.

Mycologist promotes agarikon as a possibility to counter growing antibiotic resistance

(Phys.org) —Mycologist Paul Stamets is espousing the health benefits of agarikon, a fungus that grows on trees in old growth forests in North America and Europe. He’s written and published a blog piece in the Huffington Post, describing the known antibacterial and antiviral abilities of the fungus and suggesting we take better care of our old growth forests as a means of survival in an uncertain future.

Agarikon grows to resemble a very large beehive and grows like a fruit hanging from the places where branches connect to trunks on old tall trees. Historians have noted that Native Americans mashed the fungus and used it as a medical remedy for a variety of ailments. Stamets notes that even the ancient Greeks knew about the medicinal qualities of agarikon, suggesting in an early text that it was useful for combating a host of diseases. Thereafter in Europe and the U.S. it became known as a treatment for several including consumption (tuberculosis).

Stamets has been working with the University of Illinois to more closely study the medicinal benefits of the fungi, starting shortly after 9/11. He and the team there found that administration of agarikon showed anti-tubular activity when testing against the tuberculosis bacteria, reaffirming ancient beliefs. They also reaffirmed that eating the fungi can reduce inflammation and that it can be used to help combat both bacterial and viral infections. Thus far, he reports, research has shown strong activity against cowpox, swine and bird flu and the virus that causes herpes. In some instances, he notes the effectiveness was better in some cases than conventional therapies. He claims also that thus far there is no indication that agarikon is toxic to humans.

Iron, sulfur and purple light unlock greener carbon-carbon bond formation

Much of organic chemistry, including the type used to create and alter medicinal drugs, relies on modifying carbon bonds. Rice University’s Julian West has been developing a less expensive, faster and more environmentally friendly way to catalyze these reactions, with a breakthrough published in the journal Nature Catalysis.

“Our work is essentially that of molecular architects. In my lab, we are particularly interested in using inexpensive and easily available building blocks to build and modify organic compounds,” said West, an assistant professor of chemistry and corresponding author of the study.

“Now, we’ve adapted our cheap and environmentally friendly method to precisely and specifically bind a carbon to other carbons, an essential reaction for making organic molecules.”

Quantum models predict lung cancer using limited training data in preliminary tests

Developing reliable machine learning models for health care can be challenging when only small datasets are available. This challenge motivates research into whether quantum computing approaches can learn useful patterns from limited symptom and risk-factor data.

A research team, led by Arslan Munir, Ph.D., professor in Florida Atlantic University’s Department of Electrical Engineering and Computer Science within the College of Engineering and Computer Science, and director of the Intelligent Systems, Computer Architecture, Analytics, and Security Laboratory, evaluated quantum machine learning approaches in simulation and on quantum hardware using symptom and risk-factor data for lung cancer prediction under limited training data.

The study, published in Discover Quantum Science, “Inferring lung cancer under limited learning data through gate-based and annealing-based quantum techniques,” provides a common framework for evaluating different quantum machine learning methods under the same data preparation and testing conditions.

MIT engineers create nanoparticles for delivering personalized cancer vaccines

A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines.

The backbone of the vaccine is a modified, harmless bacteriophage called M13, which forms a nanofiber that can be coated with cancer antigens. By precisely controlling the density of those cancer proteins, the researchers found that they could create a vaccine that prevents the development of colon tumors in mice.

This type of delivery particle could be adapted to carry many different antigens, allowing for the creation of personalized vaccines to treat individual patients’ tumors, the researchers say.